Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP · 7 quarters on record
This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in TERNS PHARMACEUTICALS INC (TERN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 443,777 | -345,869 | -43.8% | 9.60% | $17.9M | $40.40 |
| 2025 Q3 | REDUCED | 789,646 | -497,035 | -38.6% | 5.84% | $5.9M | $7.51 |
| 2025 Q2 | REDUCED | 1,286,681 | -70,472 | -5.2% | 5.68% | $4.8M | $3.73 |
| 2025 Q1 | REDUCED | 1,357,153 | -663,409 | -32.8% | 4.46% | $3.7M | $2.76 |
| 2024 Q4 | ADDED | 2,020,562 | +672,016 | +49.8% | 9.69% | $11.2M | $5.54 |
| 2024 Q3 | ADDED | 1,348,546 | +392,004 | +41.0% | 9.84% | $11.2M | $8.34 |
| 2024 Q2 | INITIATED | 956,542 | — | — | 8.21% | $6.5M | — |
As of 2025 Q4 — sorted by position size